comprehensive -WSS

comprehensive

author：knowledge 2025-09-07 06:40:52 - browse：93

Smartphone & medicine illustration — Alex Hogan/STAT

Pear Therapeutics may be gone, but one of its most important deals is still driving critical conversations about how medical apps can find a foothold in the slow-moving health care system.

In recent months, representatives of the Massachusetts state Medicaid program, MassHealth, have been presenting data suggesting reSET and reSET-O, Pear’s prescription apps that treat substance use disorder and opioid use disorder, saved the state money over a one-year period from 2021 to 2022. The data, which take into account health care utilization before and after people used the apps, have been presented to policymakers considering how to cover novel digital health products and shown to lawmakers considering federal legislation that would require Medicare coverage for prescription apps.

Pear, which filed for bankruptcy earlier this year, was one of the leading companies marketing prescription digital therapeutics, or Food and Drug Administration-cleared apps designed to treat disease. Pear’s reSET was the first such app cleared by the FDA in 2017.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Bryan Kohberger seeks indictment dismissal in Idaho college killings case

WSS

Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

Biden to sign 'historic' executive order on how US military handles sexual assault cases

Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

Suspects arrested after 3 women attacked on Manhattan's West Side: Police

Trump Organization, Michael Cohen agree to settle million

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

Wikipedia

comprehensive

leisure time

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

'Hero' Louisville officer shot in head at mass shooting discharged over 3 months later

Medicare details structure of new drug price negotiation program

Moscow blames Kyiv for missile attacks in southern Russia as Kremlin forces pound Ukrainian village

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

How Brent Saunders' Allergan experiment failed

Bright Health sells Medicare Advantage business to Molina

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

Trump demands the U.S. pay no more for drugs than other countries … again

Reframing the conversation around gain

hotspot

Suspects arrested after 3 women attacked on Manhattan's West Side: Police

Listen: BridgeBio's big week & Lilly's Alzheimer's data

It's time to take a new tack for treating Alzheimer's

Bryan Kohberger seeks indictment dismissal in Idaho college killings case

A new deal aims to ramp up use of AI in rehab care decisions

New chief aims to remake Sanofi Genzyme

focus

Wikipedia

focus

hotspot